At almost $2,200 a pop, it’s probably no surprise that we get lots of questions about generic Lucentis. If you are an age-related macular degeneration (AMD) patient, Lucentis is the only FDA-approved treatment for the wet-form of AMD, but unfortunately, it’s also incredibly pricey, so we get questions all the time about What’s going on . . . → Read More: Will Generic Lucentis Ever Be Available in the U.S.?

Follow Us!